Research Article
Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study
Table 1
Baseline patient characteristics.
| | Characteristics | Value |
| | Age (years, mean ± SD) | 53.8 ± 20.9 | | Sex (n, male/female) | 20/16 | | Kidney biopsy diagnosis (n, MCNS/non-MCNS) | 18/18 | | u-PCR (g/gCr, mean ± SD) | 10.9 ± 5.9 | | Selectivity index (mean ± SD) | 0.19 ± 0.10 | | u-suPAR (pg/mgCr, mean ± SD) | 3774.2 ± 1965.7 | | u-L-FABP (μg/gCr, median (IQR)) | 39.5 (19.8–83.1) | | eGFR (mL/min/1.73 m2, mean ± SD) | 59.8 ± 25.0 | | s-Albumin (g/dL, mean ± SD) | 1.8 ± 0.5 | | Total cholesterol (mg/dL, mean ± SD) | 351.3 ± 123.0 | | s-suPAR (pg/mL, mean ± SD) | 3488.7 ± 1641.9 | | Cyclosporine use in initial treatment (n, use/nonuse) | 29/7 |
|
|
SD, standard deviation; MCNS, minimal-change nephrotic syndrome; s-, serum; u-, urinary; PCR, protein-to-creatinine ratio; suPAR, soluble urokinase plasminogen activator receptor; L-FABP, liver-type fatty acid-binding protein; eGFR, estimated glomerular filtration rate.
|
